Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study.
- DOI
- 10.1016/j.eclinm.2025.103681
- Published
- 2025 Dec
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2025.103681,
title = {Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study.},
author = {Oostwouder CJ and Vos K and Lutke Schipholt IJ and Merkus MR and Telders T and van Deursen DFA and de Smit MB and van Eijk MD and Bontkes HJ and Bouwman FH and Wüst RCI and de Jong L and van Hulst M and Twisk JWR and van Kalken CK and Scholten-Peeters GGM},
year = {2025},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2025.103681},
url = {https://doi.org/10.1016/j.eclinm.2025.103681}
}RIS
TY - JOUR TI - Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study. AU - Oostwouder CJ AU - Vos K AU - Lutke Schipholt IJ AU - Merkus MR AU - Telders T AU - van Deursen DFA AU - de Smit MB AU - van Eijk MD AU - Bontkes HJ AU - Bouwman FH AU - Wüst RCI AU - de Jong L AU - van Hulst M AU - Twisk JWR AU - van Kalken CK AU - Scholten-Peeters GGM PY - 2025 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2025.103681 UR - https://doi.org/10.1016/j.eclinm.2025.103681 ER -
APA
CJ, O., K, V., IJ, L. S., MR, M., T, T., DFA, V. D., MB, D. S., MD, V. E., HJ, B., FH, B., RCI, W., L, D. J., M, V. H., JWR, T., CK, V. K., & GGM, S. (2025). Effect of subcutaneous lidocaine-hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2025.103681
Source records
- pubmed · retrieved 2026-09-25T20:29:40.428Z